Abiomed (ABMD) Posts Q2 Loss of $0.21, In-Line with Estimates
ABMD Hot Sheet
EPS Growth %: +1,200.0%Financial Fact:
Research and development: 6.14M
Today's EPS Names:
SAPX, ECTY, TRNS, More
Abiomed, Inc. (NASDAQ: ABMD) reports Q2 loss of $0.21, even with the analyst estimate of ($0.21). Revenue for the quarter was $20.02 million, which compares to the estimate of $20.14 million.
You May Also Be Interested In
- UPDATE: Lowe's (LOW) Beats Q1 Views Amid Lagging Seasonal Demand; Issues Light FY12 Earnings Outlook
- Daqo New Energy (DQ) Posts Q1 Loss of 39c/Share; Guides Q2 Shipments
- Lowes Cos. (LOW) Tops Q1 EPS by 1c; Guides FY12 EPS Below Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
